Related Experiment Video
Updated: Aug 7, 2026
14:24
An Appetitive Spatial Working Memory Task for Mice in a Semi-Automated 8-Arm Radial Maze, Reducing Fearful Memory Association in the Maze
Published on: July 29, 2025
Gomisin A improves scopolamine-induced memory impairment in mice
Dong Hyun Kim1, Tran Manh Hung, Ki Hwan Bae
1Department of Oriental Pharmaceutical Science, College of Pharmacy, Kyung Hee University, #1 Hoeki-dong, Dongdeamoon-ku, Seoul 130-701, South Korea.
European Journal of Pharmacology
|July 11, 2006
Summary
Gomisin A, derived from Schizandra chinesis, effectively reversed scopolamine-induced memory deficits in mice. This natural compound shows promise for treating cognitive impairments by enhancing the cholinergic system.
Area of Science:
- Pharmacology
- Neuroscience
- Traditional Chinese Medicine
Background:
- Schizandra chinesis fruits are utilized in traditional Chinese medicine as a tonic.
- Gomisin A is a key component isolated from Schizandra chinesis.
- Cognitive impairments, such as those induced by scopolamine, represent a significant health concern.
Purpose of the Study:
- To evaluate the efficacy of Gomisin A in ameliorating scopolamine-induced learning and memory impairments in a mouse model.
- To investigate the potential mechanisms underlying the cognitive-enhancing effects of Gomisin A.
Main Methods:
- Cognitive function was assessed using behavioral tests: passive avoidance, Y-maze, and Morris water maze.
- Scopolamine was administered to induce amnesia in mice.
- In vitro studies were conducted to measure the effect of Gomisin A on acetylcholinesterase activity.
Main Results:
- Gomisin A (5 mg/kg) significantly reversed scopolamine-induced cognitive deficits in the passive avoidance and Y-maze tests.
- Gomisin A administration improved escape latency in the Morris water maze test.
- Gomisin A demonstrated dose-dependent inhibition of acetylcholinesterase activity in vitro (IC50 = 15.5 μM).
Conclusions:
- Gomisin A exhibits significant cognitive-enhancing properties.
- The beneficial effects of Gomisin A on cognition appear to be mediated, at least in part, by the enhancement of the cholinergic nervous system.
- Gomisin A is a potential therapeutic agent for cognitive impairment.
